Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels.
Krug, Lee M
Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Oct 2007 - 947-52 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1556-1380
10.1097/JTO.0b013e3181560dcc doi
Adult
Aged
Antibodies, Monoclonal--pharmacokinetics
Antibodies, Monoclonal, Humanized
Bone Neoplasms--immunology
Brain Neoplasms--immunology
Carcinoma, Small Cell--immunology
Female
Humans
Indium Radioisotopes--pharmacokinetics
Lewis Blood Group Antigens--metabolism
Liver Neoplasms--immunology
Lung Neoplasms--immunology
Male
Middle Aged
Pilot Projects
Radioimmunotherapy--methods
Time Factors
Tissue Distribution
Treatment Outcome
Targeting Lewis Y (Le(y)) in small cell lung cancer with a humanized monoclonal antibody, hu3S193: a pilot trial testing two dose levels. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer Oct 2007 - 947-52 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1556-1380
10.1097/JTO.0b013e3181560dcc doi
Adult
Aged
Antibodies, Monoclonal--pharmacokinetics
Antibodies, Monoclonal, Humanized
Bone Neoplasms--immunology
Brain Neoplasms--immunology
Carcinoma, Small Cell--immunology
Female
Humans
Indium Radioisotopes--pharmacokinetics
Lewis Blood Group Antigens--metabolism
Liver Neoplasms--immunology
Lung Neoplasms--immunology
Male
Middle Aged
Pilot Projects
Radioimmunotherapy--methods
Time Factors
Tissue Distribution
Treatment Outcome